Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

NPHP1 Gene (Nephronophthisis Type 1) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين NPHP1 (التهاب الكلية النسيجي النوع الأول) بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary | ملخص تنفيذي

  • Accuracy Guarantee: 99.9 % diagnostic sensitivity via ISO‑accredited NGS processing with confirmatory Sanger sequencing.
  • Premium Logistics: Paid hospital‑grade home collection (8 AM – 11 PM) using ISO‑certified cold‑chain transport and VIP mobile phlebotomy.
  • Clinical Guidance: Complimentary telephonic post‑test clinical interpretation session with a genetic counsellor.
  • Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
  • ملخص تنفيذي: اختبار دقيق بنسبة 99.9% لتشخيص التهاب الكلية النسيجي من النوع الأول، يتوافق مع معايير هيئة الصحة بدبي 2026، مع خدمة سحب منزلي وإرشاد سريري بعد النتيجة.

Test Overview

This NGS‑based genetic test reads the entire coding sequence of the NPHP1 gene to identify DNA variants responsible for nephronophthisis type 1, an inherited cystic kidney disease that often leads to end‑stage renal failure in childhood. يقرأ الاختبار الجيني الكامل لجين NPHP1 لتحديد الطفرات المسببة لالتهاب الكلية النسيجي.

Feature Our NPHP1 NGS Test Standard Single‑Gene Sanger Sequencing
Precision Full gene coverage (exons, intron‑exon boundaries, CNV detection) Limited to pre‑selected coding regions; may miss deep intronic or CNV variants
Methodology NGS (Illumina platform) + orthogonal Sanger confirmation Sanger sequencing (targeted PCR amplification)
Turnaround Time 3–4 weeks 4–6 weeks (due to iterative primer design)
Diagnostic Yield ~95 % for NPHP1‑related phenotype (including deletions) ~80 % (misses large deletions unless MLPA added separately)
Cost (UAE) 2800 AED 3200–3500 AED (if MLPA added)

Physician Insight & Safety Protocol

“This test provides critical diagnostic clarity, but I always remind families that a genetic result must be integrated with ultrasound, kidney function tests, and clinical history. A variant of uncertain significance does not confirm disease; genetic counselling before and after testing is essential to understand the implications for the child and extended family.” – Dr. PRABHAKAR REDDY, DHA License 61713011

Medication Warning

Do not discontinue or adjust any prescribed medication (antihypertensives, diuretics, immunosuppressants) without consulting your treating physician. This test does not replace ongoing nephrology follow‑up.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Active febrile illness or blood transfusion within the last 2 weeks – may interfere with DNA quality. Postpone collection until medically stable.
  • Exclusion: Unsupervised minors without legal guardian consent as per UAE CDS Law 2026 (Minors Protection).
  • ER Red Flags: Sudden drop in urine output (oliguria/anuria), hypertensive crisis (BP ≥ 180/120 mmHg), severe electrolyte disturbance – seek immediate emergency care.

Frequently Asked Questions (FAQ) / الأسئلة الشائعة

What is the NPHP1 NGS test, and why is it ordered?

Snippet: The NPHP1 NGS test sequences the entire NPHP1 gene to detect pathogenic variants causing nephronophthisis type 1, a progressive childhood kidney disease.

It is requested when a child presents with polyuria, polydipsia, anemia, growth retardation, or renal ultrasound showing small, hyperechoic kidneys with loss of corticomedullary differentiation. It also confirms carrier status in family members.

ما هو اختبار NPHP1 بتقنية NGS ولماذا يُطلب؟

الفحص: يقوم الاختبار بتسلسل جين NPHP1 الكامل للكشف عن الطفرات المسببة لالتهاب الكلية النسيجي من النوع الأول، وهو مرض كُلوي وراثي تقدمي يصيب الأطفال.

How do I prepare for the, and what sample is needed?

Snippet: You must attend a genetic counselling session to draw a pedigree chart before providing a blood sample, extracted DNA, or a single drop on an FTA card.

Fasting is not required. The phlebotomist collects 2‑5 mL of whole blood in an EDTA tube. A dedicated cold‑chain courier transports the sample to the laboratory within 4 hours to maintain DNA integrity.

كيف أستعد للاختبار وما العينة المطلوبة؟

التحضير: يجب حضور جلسة استشارة وراثية لرسم شجرة العائلة قبل تقديم عينة دم أو DNA مستخلص أو قطرة دم على بطاقة FTA.

When will I receive my results, and how are they explained?

Snippet: The report is issued within 3–4 weeks and includes a plain‑language interpretation along with a telephonic clinical guidance session by a genetics professional.

Results categorise variants as pathogenic, likely pathogenic, uncertain significance (VUS), likely benign, or benign. A face‑to‑face or telehealth follow‑up with your nephrologist is strongly recommended to integrate the genetic finding with your clinical picture.

متى أحصل على النتيجة وكيف تُفسَّر؟

النتيجة: يصدر التقرير خلال 3–4 أسابيع ويتضمن تفسيراً واضحاً إلى جانب جلسة إرشاد هاتفية مع أخصائي وراثة.

This service complies with Federal Decree‑Law No. 41 of 2024 (Medical Liability, Art. 87), UAE Consumer Data Privacy Law (PDPL), and CDS Law 2026 for minor patients. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453.

Clinical consultation: Dr. PRABHAKAR REDDY, DHA 61713011. Support: +971 54 548 8731 (WhatsApp).

For medical emergencies, call 998 or visit the nearest Emergency Department.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians